Company profileNeural interface
Merge Labs
A research-stage company pursuing non-implanted interfaces based on ultrasound and molecular methods.
- Location
- United States
- Founded
- 2025
- Class
- Neural interfaceNot counted among core BCI companies.
- Funding stage
- Seed
- Sources last checked
- Awaiting a source check
What they are building
Emerged from stealth in January 2026 with a $252M seed round to develop brain interfaces that do not rely on implanted electrodes.
- Interface category
- Focused ultrasound neuromodulation · Functional ultrasound imaging
- Signal
- tFUS: Pulsed low-intensity ultrasoundfUS imaging: Blood-volume changes at depth
- Invasiveness
- Non-invasive
- Recording / stimulation
- Recording and stimulation
- Main use cases
- Augment, Restore
Where they are clinically
Preclinical
Bench, animal or cadaver work. No human participants.
Access today
Concept
A proposed approach without published human or animal demonstration.
- Shown in people
- Nothing public: no device, animal or human data.
- Still an aim
- High-bandwidth reading and writing without implanted electrodes, by ultrasound and molecular methods.
- What stands in the way
- Physics first: functional ultrasound in people has needed a window in the skull.
On record here: 0 peer-reviewed papers
This technology remains experimental and is not an established treatment. Access is limited to registered clinical studies.
Why this company matters
At its launch in January 2026, Merge Labs was the largest bet yet placed on reaching high bandwidth without an implant. There is no public human or device data yet, so its position on any maturity scale is a statement about ambition and capital, not evidence.
Key milestones
14 Jan 2026
Emerges from stealth with a $252M seed round; OpenAI and Bain Capital reported as lead backers.
Funding history
- 14 Jan 2026$252MSeed · led by OpenAI, Bain Capital
Investors namedOpenAI · Bain Capital
Rounds in the Briefing’s sample only; not a complete funding history.
Leadership
Sam Altman
Co-founder
Mikhail Shapiro
Co-founder
As publicly stated by the organisation. Not a complete list.
Competitive context
Sources
- 01
OpenAI invests in brain-interface biz co-founded by CEO Sam Altman (opens in a new tab)
Independent reportingThe Register16 Jan 2026Source identified, not opened